Trials / Sponsors / PCI Biotech AS
PCI Biotech AS
Industry · 6 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Terminated | PCI Treatment/Gemcitabine & Chemotherapy vs Chemotherapy Alone in Patients With Inoperable Extrahepatic Bile D Cholangiocarcinoma | Phase 2 | 2019-05-23 |
| Completed | Study to Assess Safety, Tolerability and Immune Response of Fimaporfin-induced Photochemical Internalisation o Healthy Volunteer | Phase 1 | 2016-09-01 |
| Completed | A Phase I/II Safety and Efficacy Study of PCI of Gemcitabine and Chemotherapy in Patients With Cholangiocarcin Cholangiocarcinoma | Phase 1 | 2013-05-01 |
| Terminated | A Study to Evaluate the Safety and Efficacy of Amphinex Induced PCI of Bleomycin for Recurrent Head and Neck C Recurrent Head and Neck Cancer, Carcinoma, Squamous Cell of Head and Neck | Phase 2 | 2012-04-01 |
| Completed | Dose Escalating Study for Amphinex-based PCI of Bleomycin. Cutaneous or Sub-cutaneous Malignancies | Phase 1 | 2012-01-01 |
| Completed | Safety Study of Amphinex Based Photochemical Internalisation (PCI) of Bleomycin in Patients With Cutaneous Can Head and Neck Neoplasms, Skin Neoplasms | Phase 1 | 2009-08-01 |